These trials , built on encouraging data from pooled analysis of early trials ( HERMES collaboration ) and emerging retrospective data , are studying large vessel occlusion strokes with mild deficits ( National Institutes of Health Stroke Scale < 6 ) and large infarct burden ( core volume > 70 mL ) .